Poultry Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Market is Segmented by Test Type (ELISA, PCR, Molecular Diagnostic Test, and More), Disease Type (Infectious Diseases, Parasitic Diseases, and More), by Service(Bacteriology, Virology, and More), End User (Veterinary Reference Laboratories, and More) and by Geography. The Market Sizes and Forecasts are Provided in Terms of Value (USD).

Poultry Diagnostics Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Poultry Diagnostics Market with other markets in Healthcare Industry

Poultry Diagnostics Market Analysis by Mordor Intelligence

The poultry diagnostics market is valued at USD 0.93 billion in 2025 and is forecast to reach USD 1.49 billion by 2030, advancing at a 9.85% CAGR. The growth reflects widespread adoption of sophisticated flock-health programs, the shift toward molecular confirmation of emerging pathogens, and tighter surveillance requirements that link export access to documented testing. Government vaccination and monitoring schemes following recent highly pathogenic avian influenza episodes reinforce steady demand for routine screening, while artificial-intelligence tools that analyze hatchery data in real time are moving diagnostics from a reactive function to a preventive pillar. Integrated producers are standardizing testing protocols across multi-site operations to protect high-value genetics, and reference laboratories are scaling automation to mitigate persistent shortages of trained technologists. In parallel, point-of-care devices are gaining traction on farms that cannot wait for off-site results, giving the poultry diagnostics market additional momentum in low-infrastructure regions.

Key Report Takeaways

  •  By test type, ELISA led with 46.12% revenue share in 2024, while PCR is projected to post the fastest 10.45% CAGR through 2030.
  • By disease type, infectious diseases accounted for 38.15% of the poultry diagnostics market share in 2024; parasitic diseases are on track for a 10.82% CAGR to 2030.
  • By service type, bacteriology held 32.71% of the poultry diagnostics market size in 2024, whereas virology is set to expand at 11.03% CAGR.
  • By end user, veterinary reference laboratories captured 43.20% share in 2024; on-farm point-of-care units record the highest 11.35% CAGR outlook.
  • By geography, North America dominated with 42.19% revenue share in 2024, but Asia-Pacific is the fastest-rising region at 11.86% CAGR.

Segment Analysis

By Test Type: Molecular Technologies Drive Innovation

ELISA generated 46.12% of global revenue in 2024, reflecting its role as the backbone of surveillance and vaccination monitoring. These assays combine low cost with reliable throughput, which keeps them entrenched even as new modalities emerge. The poultry diagnostics market size for ELISA-based offerings stood at USD 0.43 billion in 2025 and is forecast to edge past USD 0.62 billion by 2030. PCR platforms, while starting from a lower baseline, are projected to record 10.45% CAGR, driven by regulatory mandates for molecular confirmation during H5 or H7 outbreaks. Manufacturers bundle validated reagents with automated thermocyclers, reducing hands-on time and contamination risk. Next-generation sequencing panels sit at the cutting edge, capable of characterizing entire viromes in a single workflow, yet remain confined to reference laboratories until costs fall further.

The lateral-flow segment addresses on-farm triage needs with cartridges that deliver qualitative answers within 15 minutes. Demand rises where immediate culling decisions can avert severe financial losses, especially in integrated operations that house millions of birds. Hemagglutination-inhibition tests, still required by several export authorities, continue to secure a niche share. Vendors now develop digital-image capture solutions that interpret titer patterns objectively, improving consistency. Together, these dynamics ensure that the poultry diagnostics market offers a wide technology continuum, allowing users to balance price, speed and sensitivity.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Disease Type: Infectious Pathogens Retain Primacy

Infectious agents commanded 38.15% revenue share in 2024 and remain the economic focal point for producers wary of trade bans and mass depopulation orders. Sample submissions spike each winter when migratory birds intersect commercial flocks in the northern hemisphere, underscoring the seasonal volatility embedded in the poultry diagnostics market. The sector responds with multiplex PCR panels detecting avian influenza, Newcastle disease and infectious bronchitis in a single run, improving cost efficiency. Researchers also refine DIVA (Differentiation of Infected from Vaccinated Animals) assays to support widespread immunization strategies without compromising surveillance.

Parasitic diseases, led by coccidiosis, exhibit the fastest 10.82% CAGR, expanding the poultry diagnostics market size for this niche from USD 0.14 billion in 2025 to an expected USD 0.23 billion by 2030. Automated oocyst-counting instruments reduce subjectivity and staff fatigue, boosting test reliability. Concurrent interest in metabolic and nutritional disorders signals a broader trend toward precision husbandry, where wearable sensors track body temperature and activity to pre-empt welfare issues. Although these categories remain smaller today, their growth rate suggests a gradual diversification of diagnostic demand away from an exclusive pathogen focus.

By Service Type: Virology Accelerates Within Lab Menus

Bacteriology retained the top slot with 32.71% contribution in 2024 owing to food-safety driven Salmonella monitoring mandates. National programs in the United States and the European Union compel processors to demonstrate ongoing compliance, ensuring a dependable baseline for culture and serotyping services. Despite that stability, the most dynamic expansion happens in virology, which is projected to rise at 11.03% CAGR through 2030. Next-generation sequencing now supports routine viral genotyping, giving veterinarians insights into antigen drift that could erode vaccine efficacy. Reference laboratories leverage high-throughput robotics to meet soaring demand during outbreak peaks, integrating bioinformatic pipelines that deliver full reports within 48 hours.

Parasitology leverages image-analysis hardware capable of distinguishing oocyst morphology across Eimeria species, cutting analysis times from hours to minutes. Immunology and serology hold steady roles in monitoring post-vaccination antibody titers, and necropsy plus histopathology remain indispensable for complex mortality events where gross lesions guide further testing. The multi-discipline nature of laboratory menus underscores why the poultry diagnostics market rewards providers that can bundle diverse services under one roof.

Poultry Diagnostics Market: Market Share by Service Type
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End User: Point-of-Care Adoption Rises From Lower Base

Veterinary reference laboratories captured 43.20% revenue share in 2024 by offering centralized expertise and bulk pricing. IDEXX alone processes millions of avian samples annually through an international network that operates 24-hour shifts during epidemic alerts. Consolidation trends accelerate as regional labs sell to global chains seeking geographic reach. Nevertheless, on-farm testing units deliver the highest 11.35% CAGR, reflecting producers’ need for immediate action on high-density sites. Cartridge-based hematology and molecular readers now plug into mobile apps that archive data for audit compliance, narrowing the performance gap with centralized facilities.

Academic institutions and public research centers continue to pilot emerging technologies, such as CRISPR-based detection that could bypass thermocycling. While their direct share of the poultry diagnostics market remains modest, they play an outsized role in validating methodologies later adopted by the commercial sector. Collectively, the spread of competencies across end-user groups ensures resilience in diagnostic capacity and drives continuous innovation.

Geography Analysis

North America remained the largest revenue block with 42.19% share in 2024, an outcome of stringent food-safety legislation, advanced cold-chain infrastructure and widespread insurance schemes that reimburse disease-control expenses. The region invests heavily in biocontainment upgrades and supports a network of more than 60 accredited veterinary diagnostic labs that handle avian submissions, underpinning the mature demand profile. Even so, the United States faces a projected gap of qualified diagnosticians by 2030, which has prompted subsidies for automation upgrades, shaping the medium-term outlook for the poultry diagnostics market.

Asia-Pacific is the fastest-growing territory at 11.86% CAGR to 2030, underpinned by population growth, urbanization and policy drives to boost domestic protein self-sufficiency. China, India and Indonesia collectively plan multi-billion-dollar investments in slaughter and cold-storage capacity, and each mandates routine disease monitoring for export certification. Public-private partnerships fund regional laboratory networks that offer reduced-fee PCR screening, embedding diagnostics in standard production economics. As a result, the poultry diagnostics market size in Asia-Pacific is expected to surpass USD 0.42 billion by 2030, up from USD 0.24 billion in 2025.

Europe preserves steady demand through harmonized veterinary legislation and mutual-recognition protocols handled by the Veterinary Batch Release Network, ensuring cross-border movement of poultry without redundant testing. Latin America and the Middle East & Africa register double-digit growth on small absolute bases, supported by multinational integrators establishing vertically aligned complexes that include on-site laboratories. While infrastructure deficits remain in parts of Sub-Saharan Africa, multilateral donors channel grants for mobile labs that can travel between farms, setting foundations for future expansion of the poultry diagnostics market.

Poultry Diagnostics Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The poultry diagnostics market shows moderate concentration. The combined revenue of the top five suppliers sits just above 60%, giving mid-tier entrants room to specialize. IDEXX Laboratories leads global share and posted 6.56% year-over-year revenue growth in 2024 on the back of expanded molecular menus. Zoetis follows through strategic acquisitions that knitted Ethos Diagnostic Science, Phoenix Lab and ZNLabs into a unified reference-lab network covering cytology, chemistry and microbiology. Thermo Fisher Scientific leverages its qPCR franchise to supply reagents to national labs during outbreak surges.

Technology is the decisive battleground. IDEXX will launch a lymphoma-screening panel for canines in 2025, but its underlying flow-cytometry platform has avian applications that could cross-pollinate market segments. Zoetis deploys artificial-intelligence algorithms within its Vetscan Imagyst ecosystem to read fecal smears automatically, cutting analysis times for coccidiosis from 20 minutes to under 4 minutes. Emerging firms focus on portable PCR devices that work without refrigeration, targeting low-resource countries. While patents and regulatory approvals form barriers to entry, customer stickiness also arises from data-integration services that feed laboratory results directly into farm management software.

Regional manufacturers navigate local content policies by partnering with state agribusiness corporations to assemble diagnostic kits domestically. This strategy limits exposure to import tariffs and secures public-tender eligibility. Conversely, global incumbents safeguard brand equity through third-party proficiency testing that certifies assay reproducibility, a prerequisite for premium pricing. Overall, the competitive landscape remains dynamic, with innovation velocity and acquisition moves driving shifts in share allocations within the poultry diagnostics market.

Poultry Diagnostics Industry Leaders

  1. Idexx Laboratories, Inc.

  2. Zoetis, Inc.

  3. Thermo Fisher Scientific

  4. Biochek

  5. Megacor Diagnostik GmbH

  6. *Disclaimer: Major Players sorted in no particular order
Idexx Laboratories, Inc., Zoetis, Inc., Thermo Fisher Scientific, Biochek, Megacor Diagnostik GmbH
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • March 2025: Zoetis opened its 32,000-square-foot Louisville reference laboratory, co-located with UPS Healthcare Labport, to accelerate nationwide specimen logistics
  • March 2024: Netherlands-based Harch Tech Group acquired NYtor to enhance PCR-based screening aimed at improving male-chick survivability.
  • January 2024: Alveo Technologies partnered with Pharmsure International, Royal GD and x-OvO to co-develop a multiplex avian-influenza panel covering Group A, H5, H7 and H9 strains for in-situ use.

Table of Contents for Poultry Diagnostics Industry Report

1. Introduction

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions & Market Definition
  • 1.3 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Heightened Government & Ngo Surveillance Programs
    • 4.2.2 Escalating Avian-Influenza & Zoonotic Outbreaks
    • 4.2.3 Surging Demand For Poultry Protein In Emerging Economies
    • 4.2.4 Rapid Adoption Of Elisa, Pcr And Other Molecular Assays In Veterinary Reference Laboratories
    • 4.2.5 Expansion Of Large Integrated Poultry Operations
    • 4.2.6 Ai-Driven Predictive Analytics For Hatchery Health
  • 4.3 Market Restraints
    • 4.3.1 High Cost Of Molecular Tests & Consumables
    • 4.3.2 Limited Skilled Lab Workforce In Low-Income Regions
    • 4.3.3 Compliance Burden From Evolving Bio-Security Protocols
    • 4.3.4 Reagent Supply Disruptions During Trade Bans
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value)

  • 5.1 By Test Type
    • 5.1.1 ELISA
    • 5.1.2 PCR
    • 5.1.3 Lateral-Flow Immunoassays
    • 5.1.4 Hemagglutination-Inhibition & AGID
    • 5.1.5 Next-Generation Sequencing Panels
    • 5.1.6 Other Diagnostic Tests
  • 5.2 By Disease Type
    • 5.2.1 Metabolic & Nutritional Disorders
    • 5.2.2 Infectious Diseases
    • 5.2.3 Parasitic Diseases (Coccidiosis, Helminths)
    • 5.2.4 Other Disease Types
  • 5.3 By Service Type
    • 5.3.1 Bacteriology
    • 5.3.2 Virology
    • 5.3.3 Parasitology
    • 5.3.4 Serology & Immunology
    • 5.3.5 Necropsy & Histopathology
  • 5.4 By End User
    • 5.4.1 Poultry Farms & Integrators
    • 5.4.2 Veterinary Reference Laboratories
    • 5.4.3 Point-of-Care / On-Farm Testing Units
    • 5.4.4 Academic & Research Institutes
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 IDEXX Laboratories Inc.
    • 6.3.2 Zoetis Inc.
    • 6.3.3 Thermo Fisher Scientific Inc.
    • 6.3.4 GD Animal Health
    • 6.3.5 BioChek BV
    • 6.3.6 Bionote Inc.
    • 6.3.7 Boehringer Ingelheim GmbH
    • 6.3.8 Megacor Diagnostik GmbH
    • 6.3.9 QIAGEN NV
    • 6.3.10 Bio-Rad Laboratories Inc.
    • 6.3.11 Neogen Corporation
    • 6.3.12 Randox Laboratories Ltd.
    • 6.3.13 Abaxis (Zoetis)
    • 6.3.14 Virbac SA
    • 6.3.15 Fassisi GmbH
    • 6.3.16 Anigen (South Korea)
    • 6.3.17 IDEXX Asia Pacific Pte Ltd.
    • 6.3.18 Avian Diagnostics Ltd.
    • 6.3.19 Ring Biotechnology Co. Ltd.
    • 6.3.20 BioNote USA

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Poultry Diagnostics Market Report Scope

Poultry is defined as livestock that are chickens, turkeys, ducks, waterfowl and other birds raised in the farm. Poultry diagnostics are used to identify the various diseases present in poultry. Increase in demand for poultry-derived food products is propelling the market growth. The poultry diagnostics provide microbiology, serology, pathology, and toxicology services and in recent days, it is spreading across multiple organizational structures. 

By Test Type ELISA
PCR
Lateral-Flow Immunoassays
Hemagglutination-Inhibition & AGID
Next-Generation Sequencing Panels
Other Diagnostic Tests
By Disease Type Metabolic & Nutritional Disorders
Infectious Diseases
Parasitic Diseases (Coccidiosis, Helminths)
Other Disease Types
By Service Type Bacteriology
Virology
Parasitology
Serology & Immunology
Necropsy & Histopathology
By End User Poultry Farms & Integrators
Veterinary Reference Laboratories
Point-of-Care / On-Farm Testing Units
Academic & Research Institutes
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
By Test Type
ELISA
PCR
Lateral-Flow Immunoassays
Hemagglutination-Inhibition & AGID
Next-Generation Sequencing Panels
Other Diagnostic Tests
By Disease Type
Metabolic & Nutritional Disorders
Infectious Diseases
Parasitic Diseases (Coccidiosis, Helminths)
Other Disease Types
By Service Type
Bacteriology
Virology
Parasitology
Serology & Immunology
Necropsy & Histopathology
By End User
Poultry Farms & Integrators
Veterinary Reference Laboratories
Point-of-Care / On-Farm Testing Units
Academic & Research Institutes
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current Poultry Diagnostics Market size?

The poultry diagnostics market is valued at USD 0.93 billion in 2025 and is projected to reach USD 1.49 billion by 2030.

Who are the key players in Poultry Diagnostics Market?

Idexx Laboratories, Inc., Zoetis, Inc., Thermo Fisher Scientific, Biochek and Megacor Diagnostik GmbH are the major companies operating in the Poultry Diagnostics Market.

Which is the fastest growing region in Poultry Diagnostics Market?

Asia-Pacific leads growth with an expected 11.86% CAGR through 2030, driven by rapid expansion of commercial poultry farming.

Which region has the biggest share in Poultry Diagnostics Market?

In 2025, the North America accounts for the largest market share in Poultry Diagnostics Market.

Why are molecular assays gaining popularity?

Regulatory bodies increasingly require molecular confirmation during notifiable disease investigations, and automated PCR platforms deliver speed, sensitivity and reduced dependence on skilled labor.

Page last updated on: June 26, 2025

Poultry Diagnostics Market Report Snapshots